AU1711888A - Immunotherapeutic methods and compositions - Google Patents

Immunotherapeutic methods and compositions

Info

Publication number
AU1711888A
AU1711888A AU17118/88A AU1711888A AU1711888A AU 1711888 A AU1711888 A AU 1711888A AU 17118/88 A AU17118/88 A AU 17118/88A AU 1711888 A AU1711888 A AU 1711888A AU 1711888 A AU1711888 A AU 1711888A
Authority
AU
Australia
Prior art keywords
compositions
immunotherapeutic methods
immunotherapeutic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17118/88A
Inventor
Richard A. Fisher
Walter Gilbert
Kuzhalmannam L. Ramachandran
Vicki L. Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen NV filed Critical Biogen NV
Publication of AU1711888A publication Critical patent/AU1711888A/en
Assigned to BIOGEN, INC. reassignment BIOGEN, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: BIOGEN, INC., FISHER, RICHARD A.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU17118/88A 1987-04-24 1988-04-19 Immunotherapeutic methods and compositions Abandoned AU1711888A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4217887A 1987-04-24 1987-04-24
US042178 1987-04-24

Publications (1)

Publication Number Publication Date
AU1711888A true AU1711888A (en) 1988-12-02

Family

ID=21920469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17118/88A Abandoned AU1711888A (en) 1987-04-24 1988-04-19 Immunotherapeutic methods and compositions

Country Status (3)

Country Link
EP (1) EP0311675A4 (en)
AU (1) AU1711888A (en)
WO (1) WO1988008429A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621317B2 (en) * 1987-11-24 1992-03-12 Abbott Laboratories Hiv peptides and methods for detection of hiv

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6805862B1 (en) 1989-05-25 2004-10-19 Sloan-Kattering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6432402B1 (en) 1989-05-25 2002-08-13 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
DE69032855T2 (en) * 1989-05-25 1999-08-12 Sloan Kettering Inst Cancer ANTIIDIOTYPICAL ANTIBODY INDUCING AN IMMUNE RESPONSE TO A GLYCOSPHINGOLIPID AND ITS USE
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
EP0911036A3 (en) * 1992-02-11 2001-05-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Dual carrier immunogenic construct
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6017536A (en) * 1993-06-07 2000-01-25 Trimeris, Inc. Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
US6518013B1 (en) 1993-06-07 2003-02-11 Trimeris, Inc. Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
AU3334001A (en) 2000-02-10 2001-08-20 Panacos Pharmaceuticals Inc Assay for detection of viral fusion inhibitors
ATE518967T1 (en) * 2003-11-04 2011-08-15 Univ Tulane METHOD FOR PREVENTING VIRUS-CELL FUSION BY INHIBITING THE FUNCTION OF THE FUSION INITATION AREA IN RNA VIRUSES HAVING CLASS I MEMBRANE FUSOGENE ENVELOPE PROTEINS
EP1714153A2 (en) * 2004-02-06 2006-10-25 I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
US8222204B2 (en) 2006-05-03 2012-07-17 The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC Influenza inhibiting compositions and methods
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
CN101627049B (en) 2006-11-10 2012-09-05 卡拉治疗学股份有限公司 Synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
PL2170365T3 (en) 2007-06-25 2017-03-31 The Administrators Of The Tulane Educational Fund Influenza inhibiting compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
ES8705522A1 (en) * 1984-10-18 1987-05-01 Pasteur Institut Gag antigen and its use for the detection of lav infection and in immunogenic compositions
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (en) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド Synthetic peptide, and method for detecting AIDS and pre-AIDS using the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621317B2 (en) * 1987-11-24 1992-03-12 Abbott Laboratories Hiv peptides and methods for detection of hiv

Also Published As

Publication number Publication date
EP0311675A1 (en) 1989-04-19
EP0311675A4 (en) 1989-10-04
WO1988008429A1 (en) 1988-11-03

Similar Documents

Publication Publication Date Title
AU607216B2 (en) Sun protectant composition and method
AU2783689A (en) Hair-treating composition
AU1711888A (en) Immunotherapeutic methods and compositions
AU7180487A (en) Antimicrobial compositions and methods
AU2373188A (en) Sunscreen compositions
AU7491987A (en) Lattice-entrapped composition
AU1664688A (en) Thiadiazinones
AU626930B2 (en) Immunostimulatory composition
AU1381888A (en) Timeswitches
AU3008089A (en) Silyl 2-amidoacetate and silyl 3-amidopropionate compositions
AU1301788A (en) Chemo-radio-immuno-conjugates
AU1210388A (en) Novel aminohydrocarbyl-substituted ketoximosilanes
AU1626288A (en) Equal-abundance transcript composition and method
AU2174588A (en) Depilatory compositions
AU1359188A (en) Permanent wave composition
AU2390888A (en) Shampoo composition
AU3027389A (en) Compositions
AU2463988A (en) An improved method and composition
AU1134888A (en) Coccidiocidal compositions
AU1644688A (en) Polyurethane-drying oil-plasticiser compositions
AU6697086A (en) Immunoamplifiers and related compositions
AU1158888A (en) Scraper-spreader
AU1204488A (en) Herbicidal composition and method
AU4024289A (en) Selenium-sulfur compositions and uses therefor
AU2042688A (en) Heat-vulcanizable organopolysiloxane compositions